Immunotherapy post-surgery found to improve overall survival for kidney cancer
For the first time in fifty years, results from a phase 3 randomized, placebo-controlled trial have shown an overall survival benefit from an adjuvant therapy in patients with kidney cancer.
Jan 27, 2024
0
0